(Update) Report on Symposium “Global Health and Corporate Strategy: Varied and Innovative Models”
date : 12/25/2012
The symposium “Global Health and Corporate Strategy: Varied and Innovative Models” was hosted in collaboration with the GAVI Alliance and UNICEF Tokyo Office.
With
the IMF/World Bank annual general meetings was held in Tokyo in October,
attention was drawn toward the major agenda of investments into health. Under
this increased momentum, the emphasis at this symposium was on partnerships
within corporations and various organizations particularly for the solving of
global health problems. The merits, barriers and solutions to such partnerships
was discussed through the sharing of successful examples, and with a focus on
the impact produced by international social action that utilized the special
features of businesses and varied and innovative approaches it was aspired to
help solve global health problems.
(Please download our report, program and questionnaire from the right )
(You can see some parts of videos on the day from here (YouTube).)
GAVI – HGPI – UNICEF Collaborative Symposium
“Global Health and Corporate Strategy: Diverse, Innovative Partnership Models”
■Date : Thursday, October 11, 2012 from 15:00~18:00
■Venue : Fujifilm
Corporation / Midtown West Conference room (2F)
■Co-organizers: GAVI Alliance/ Health and Global Policy Institute (HGPI)/
UNICEF Tokyo Office
■Supported by the
Ministry of Foreign Affairs of Japan
■In cooperation with : RESULTS Japan
■Program
1. Opening Remarks(15:00-15:10)
– Dr. Seth Berkley (CEO, GAVI Alliance)
2. Keynote Speeches
Keynote Speeches 1(15:10-15:40)
–
Dr. Kiyoshi Kurokawa (Chairman, HGPI)
Keynote Speeches 2(15min.)
–
Dr. Tadataka Yamada(Member of the Board, Chief Medical & Scientific
Officer, Takeda Pharmaceutical Company Limited)
Break (15:40-16:00)
3. Panel Discussion: Multi-Stakeholder Partnerships in Global
Health(16:00-17:40)
Moderator: Mr. Koichi Kaneda (Senior Director, Corporate Social
Responsibility, Corporate Communication, Takeda Pharmaceutical Company Limited)
1) “Partnership Case Study –Ghana Project–”
– Dr. Yasuhiko Toride, Director of Nutrition Improvement
Projects / Associate General Manager, R&D Planning Dept., Ajinomoto Co.,
Inc.
2) “Partnership Case Study –Anti-Infective Drug–”
– Dr. Junichi Mitsuyama, Senior Operations Manager, FUJIFILM
Corporation / Director, Toyama Chemical Co., Ltd.
3) “Partnership Case Study –Vaccine &
Medicine Development for NTDs through Partnership–“
– Dr.
BT Slingsby (Director of Global Access Strategies,
Eisai Co., Ltd.)
4) “Partnership Case Study –Vaccine Bonds–”
– Mr. Satoru Yamamoto, Director, Head of International
Investors Services, FICC Sales Dept (I), Daiwa Securities
5) “Promoting Global Partnership for
Children–Case Studies and Considerations–”
– Dr. Kunihiko Chris Hirabayashi (Director, United Nations Children’s Fund Tokyo office)
Discussion (50 min)
4. Wrap-up(17:40-17:55)
– Dr. Seth Berkley (CEO, GAVI Alliance)
– Dr. Dr. Tadataka Yamada(Member of the Board, Chief Medical & Scientific
Officer, Takeda Pharmaceutical Company Limited)
– Dr. Kiyoshi Kurokawa (Chairman, HGPI)
5. Closing Remarks
– Dr.
Shiro Konuma (Director, Global Health Policy Division International Cooperation Bureau
Ministry of Foreign Affairs)(17:55-18:00)
Contact Details:
GAVI – HGPI – UNICEF Collaborative Symposium Japan Secretariat
Health and Global Policy Institute
1-11-28 Nagatacho,Chiyoda-Ku Tokyo 100-0014 Japan
E-mail: symposium1011@hgpi.org
Normal 0 0 2 false false false EN-US JA X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:標準の表; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0mm 5.4pt 0mm 5.4pt; mso-para-margin:0mm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.5pt; mso-bidi-font-size:11.0pt; font-family:”Century”,”serif”; mso-ascii-font-family:Century; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Century; mso-hansi-theme-font:minor-latin; mso-font-kerning:1.0pt;}
Registration deadline: 2012-10-09
Exhibition date:2012-10-11
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2026-02-13
[Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
-
2026-03-03
[Registration Open] Online Seminar “Implementing Chronic Kidney Disease (CKD) Measures into Society: Towards a Data-Driven Health System” (April 21, 2026)
-
2026-03-16
[Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)



